ChemBriefSyngenta to Market Mycorrhizal Technology from Israeli Firm
Syngenta will commercialize Groundwork BioAg's mycorrhiza-based products and soil carbon solutions under its own label.
chemweek · 2026-07-14 16:57 UTC
Syngenta will commercialize Groundwork BioAg's mycorrhiza-based products and soil carbon solutions under its own label.
Syngenta Vegetable Seeds has opened a new R&D technology center in El Ejido, Spain, designed to combat crop pathogens and accelerate resilient variety development. The facility integrates breeding and
Syngenta reported a 2% sales increase to $6.4 billion in Q1, driven by strong performance in China and efficiency gains. EBITDA rose 5% to $1.4 billion, supported by growth in crop protection and seed
Syngenta achieved higher EBITDA margins despite overall sales declines, while its crop protection segment recorded a 4% sales increase in 2025.
Syngenta plans to invest $130 million in a new agricultural bioscience research center in the UK. The facility will be established at the company's existing R&D hub in Jealott’s Hill.
Syngenta partners with Swiss quantum computing firm QuantumBasel to advance crop science and discovery. The collaboration seeks to utilize quantum technology for agricultural research innovations.
Syngenta targets dominance in the agricultural biologicals sector through strategic acquisitions and new US manufacturing capacity, aiming for double-digit growth while advocating for streamlined regu
Syngenta partners with SAP to implement AI and cloud solutions across its enterprise operations, aiming to modernize workflows and enhance efficiency in its agricultural and chemical business segments
Syngenta partners with French firm Amoéba to develop biocontrol solutions for cereals and field crops in the EU and UK markets. Both companies plan to negotiate a definitive distribution agreement.
Syngenta reported a sales decline despite strong EBITDA in the first nine months of the year. The seeds business grew 1% year-over-year, primarily driven by corn recovery in Argentina.